Clinical Notes

TMJ BOTOX​

COVID-19 SCREENING
----------------------------------
Patient was pre-screened per OS protocol prior to appointment.
Patient was additionally screening via phone when they arrived outside the practice and temperature was checked. 
COVID-19 Consent was completed in addition all OS paperwork . Patient signature was verified.
Room was disinfected using Super Sani-Cloth Germicidal Disposable Wipe (EPA Reg # 9480-4 ) techniques per manufactures protocols, followed by Clorox® Clean-Up® Cleaner + Bleach (EPA Reg. No. 5813-21) Spray and room dry. Room was verified by the other assistant for completion via COVID-19 Room disinfection checklist.
Patient also rinsed with 1.5% hydrogen peroxide for 30 second 


​​Progress Note
------------------
Patient seen and consulted on previous visit for TMJ Disorder

where Botox was recommended

Patient here today to get the Botox A treatment. All risk, benefit, complications discussed. Consent obtained 


ASSESSMENT / PLAN / RECOMMENDATION
---------------------------------------------------------------

BOTOX Injection - 200 Units Type A

Masseter    R :  35U    Masseter    L : 35U

Temporalis  R : 15U    Temporalis  R : 15U

Descending Trapezius

  Superior portion R :15U   L :15U

  Middle Portion    R :5U      L :5U

  Lower Portion     R :20U    L :20U

Transverse Trapezius

   Medial Portion   R: 10      L : 10U

Patient to Follow-up in 1 month

Joseph Krajekian DMD, MD, FAAOMS, DABOMS

(C) 2020 Dr. Joseph Krajekian

Telephone :  (440) 646-0597 Office 

                     (888) 774-7773 Answering Service

Fax #         :  (888) 774-7970